Prosecution Insights
Last updated: May 29, 2026

Texas Tech University System

26 pending office actions • 22 art units • 25 examiners • 0 of 26 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days

Portfolio Summary

26
Total Pending OAs
15
Non-Final OAs
8
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 26 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

13
Overdue
1
Due this week
5
Due this month
2
Due in next 60 days
5
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 26 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (13)Due ≤ 7 days (1)Due ≤ 30 days (5)Due ≤ 60 days (2)Due later (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
24
Medium (92%)
2
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only15 (58%)
§102 only7 (27%)
§112 only1 (4%)
Double-patenting only1 (4%)
Double-patenting + other2 (8%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

20
Life Sciences
77% of docket
1
Information Tech
4% of docket
0
Communications
0% of docket
2
Semiconductors
8% of docket
3
Mechanical / Eng
12% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

260 h
Manual time on pending OAs
52 h
Time saved (low, 20%)
91 h
Time saved (mid, 35%)
2.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FUBARA, BLESSING M 2 61.9% +34.3%
DANGOL, ASHESH 1 69.3% +48.1%
SOSNOWSKI, DAVID E 1 68.1% +9.9%
LEMBO, AARON LLOYD 1 81.0% +13.3%
LIN, ERICA S Y 1 85.9% +2.3%
NGUYEN, KIET TUAN 1 88.8% -0.1%
DELEO, VICTORIA LYNN 1 37.5% -39.1%
LADD, CAROLYN LOUISE 1 57.3% +47.1%
NOTTINGHAM, KYLE GREGORY 1 60.8% +33.8%
YOUNGBLOOD, WILLIAM JUSTIN 1 63.5% +38.8%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18685163 VACUUM CALORIMETER COMPRISING AN OPEN SYSTEM DIFFERENTIAL CALORIMETER LIN, ERICA S Y 11d overdue
18692964 In-Situ Hydrogen Generation and Production From Petroleum Reservoirs LEMBO, AARON LLOYD 12d
18541426 NANOPARTICLE SIZE AND ELEMENTAL COMPOSITION CHARACTERIZATION NGUYEN, KIET TUAN 28d

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
19119348 AIRCRAFT WITH DUCTED PROPULSION DANGOL, ASHESH 6d
18692964 In-Situ Hydrogen Generation and Production From Petroleum Reservoirs LEMBO, AARON LLOYD 12d
18256449 BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders LADD, CAROLYN LOUISE 13d
18037732 THERAPIES FOR CANCER USING SMALL MOLECULES THAT BIND TO AND INHIBIT RAL INTERACTING PROTEINS YOUNGBLOOD, WILLIAM JUSTIN 35d
19186888 TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION FUBARA, BLESSING M 53d
17909480 TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION FUBARA, BLESSING M 68d
18323277 SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING INFLAMMATORY CONDITIONS NOTTINGHAM, KYLE GREGORY 83d

Top Art Units

Art UnitApps
1629 3
1613 2
1662 2
3642 1
3673 1
3672 1
2853 1
2881 1
1622 1
1621 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19186888 TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION FUBARA, BLESSING M 1613 §103 Non-Final OA 53d Pending Apr 23, 2025
19119348 AIRCRAFT WITH DUCTED PROPULSION DANGOL, ASHESH 3642 §103 Non-Final OA 6d Pending Apr 08, 2025
18833366 BACK WEDGE SOSNOWSKI, DAVID E 3673 §103 Non-Final OA 42d overdue Pending Jul 25, 2024
18692964 In-Situ Hydrogen Generation and Production From Petroleum Reservoirs LEMBO, AARON LLOYD 3672 §103 Non-Final OA 12d Pending Mar 18, 2024
18685163 VACUUM CALORIMETER COMPRISING AN OPEN SYSTEM DIFFERENTIAL CALORIMETER LIN, ERICA S Y 2853 §103 Non-Final OA 11d overdue Pending Feb 20, 2024
18541426 NANOPARTICLE SIZE AND ELEMENTAL COMPOSITION CHARACTERIZATION NGUYEN, KIET TUAN 2881 §102 Non-Final OA 28d Pending Dec 15, 2023
18290113 TISSUE-CULTURE INDEPENDENT GENE EDITING OF CELLS BY A LONG-DISTANCE RNA TRANSPORT SYSTEM DELEO, VICTORIA LYNN 1662 §103 Final Rejection 77d Pending Nov 09, 2023
18256449 BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders LADD, CAROLYN LOUISE 1622 §112 Non-Final OA 13d Pending Jun 08, 2023
18323277 SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING INFLAMMATORY CONDITIONS NOTTINGHAM, KYLE GREGORY 1621 DP Non-Final OA 83d Pending May 24, 2023
18037732 THERAPIES FOR CANCER USING SMALL MOLECULES THAT BIND TO AND INHIBIT RAL INTERACTING PROTEINS YOUNGBLOOD, WILLIAM JUSTIN 1629 §102 Final Rejection 35d Pending May 18, 2023
18085024 MODIFIED SEEDS AND PLANTS WITH RESISTANCE TO ENVIRONMENTAL STRESS AND METHODS OF USING THE SAME ORDAZ, CHRISTIAN JOSE 1663 §103 Non-Final OA 25d overdue Pending Dec 20, 2022
18011453 PROCESSES FOR ELECTROCHEMICAL UP-CYCLING OF PLASTICS AND SYSTEMS THEREOF WONG, EDNA 1795 §103 Non-Final OA 36d overdue Pending Dec 19, 2022
17918512 METHODS AND SYSTEMS FOR QUANTUM COMPUTATIONAL CHEMISTRY MODELING CHAVEZ, ANTHONY RAY 2186 §103 Non-Final OA 37d overdue Pending Oct 12, 2022
17956249 DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS BORI, IBRAHIM D 1629 §102 Non-Final OA 86d Pending Sep 29, 2022
17909480 TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION FUBARA, BLESSING M 1613 DPOther Non-Final OA 68d Pending Sep 06, 2022
17908999 MODIFIED TETRACYCLINES FOR TREATMENT OF ALCOHOL USE DISORDER, PAIN AND OTHER DISORDERS INVOLVING POTENTIAL INFLAMMATORY PROCESSES HOWELL, THEODORE R 1628 DPOther Final Rejection 71d Pending Sep 02, 2022
17908497 COMPOSITIONS AND METHODS FOR REPELLING ANIMALS FROM AN OBJECT SHIN, MONICA A 1616 §103 Non-Final OA 99d overdue Pending Aug 31, 2022
17782768 METHOD AND COMPOSITIONS FOR ENGINEERING GRAPEVINE RED BLOTCH VIRUS-RESISTANT GRAPEVINE RADOSAVLJEVIC, ALEKSANDAR 1662 §103 Non-Final OA 13d Pending Jun 06, 2022
17630975 Microfluidic Pipette Aspirators for Large-Scale Analysis of Single Cells, Clusters and Their Sub-Populations KUMAR, SRILAKSHMI K 1798 §102 Non-Final OA 126d overdue Pending Jan 28, 2022
17616287 Thermodynamic Formulation for Langmuir Adsorption Isotherms SANFORD, DIANA PATRICIA 1687 §103 Non-Final OA 51d overdue Pending Dec 03, 2021
17521773 SYSTEM AND METHOD FOR ASSESSING EMBRYO VIABILITY HUANG, MICKEY NMN 1758 §102 Final Rejection 29d Pending Nov 08, 2021
17421671 Small Molecule Analogs Of The Protein E4ORF1 In The Treatment And Prevention Of Metabolic Disorders PECKHAM, RICHARD GRANT 1627 §103 Final Rejection 9d overdue Pending Jul 08, 2021
17290987 NOVEL SELECTIVE KAPPA OPIOID RECEPTOR ANTAGONISTS AND METHODS RELATED THERETO SEITZ, ANTHONY JOSEPH 1629 §102 Final Rejection 11d overdue Pending May 03, 2021
17284525 Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes YAO, LEI 1642 §103 Final Rejection 35d overdue Pending Apr 12, 2021
16307298 Method and Composition For Reducing Pathogens in Pet Food Using Lactic Acid Bacteria DAVIS, RUTH A 1699 §103 Final Rejection 100d overdue Pending Apr 13, 2020
16310981 Method and Composition for Reducing Pathogens in Rendered Food Products Using Lactic Acid Bacteria GOUGH, TIFFANY MAUREEN 1651 §102 Non-Final OA 74d overdue Pending Dec 18, 2018

Managing Texas Tech University System's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month